Evidence map›Paper›PMID 37130465›Full record

ArticleEuropean journal of cancer (Oxford, England : 1990)2023

Letter re: SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.

Atsunori Baba, Takuya Tokunaga, Koichi Sakasegawa, Takuro Kanekura, Hirohito Tsubouchi

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in European journal of cancer (Oxford, England : 1990), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Atsunori BabaDepartment of Dermatology, Kagoshima City Hospital, 1-37 Uearata-cho, Kagoshima 890-8760, Japan. Electronic address: baba-a16@kch.kagoshima.jp.
Takuya TokunagaDepartment of General Thoracic Surgery, Kagoshima City Hospital, 1-37 Uearata-cho, Kagoshima 890-8760, Japan. Electronic address: tokunaga-t90@kch.kagoshima.jp.
Koichi SakasegawaDepartment of General Thoracic Surgery, Kagoshima City Hospital, 1-37 Uearata-cho, Kagoshima 890-8760, Japan. Electronic address: sakasegawa-k98@kch.kagoshima.jp.
Takuro KanekuraDepartment of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan. Electronic address: takurok@m2.kufm.kagoshima-u.ac.jp.
Hirohito TsubouchiDepartment of Gastroenterology, Kagoshima City Hospital, 1-37 Uearata-cho, Kagoshima 890-8760, Japan. Electronic address: tsubouchi-h62@kch.kagoshima.jp.
Kagoshima City Hospital · JPKagoshima University · JPKagoshima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autoimmune DiseasesCOVID-19COVID-19 VaccinesNeoplasms, Glandular and EpithelialHumansSARS-CoV-2Thymus NeoplasmsCOVID-19 Vaccines

Identifiers

PMID37130465
PMCPMC10148959
OpenAlexW4367550692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.